Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
Authors
Keywords
Tuberculosis, Multidrug resistance, Host-directed therapies, Immunomodulatory agents, Immune response, Inflammation
Journal
BMC Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-14
DOI
10.1186/s12916-016-0635-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial
- (2015) Nestan Tukvadze et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- LAG3 Expression in Active Mycobacterium tuberculosis Infections
- (2015) Bonnie L. Phillips et al. AMERICAN JOURNAL OF PATHOLOGY
- Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection
- (2015) Jacob Nelson et al. ANTIVIRAL RESEARCH
- Mesenchymal Stromal Cell Therapy in MDR/XDR Tuberculosis: A Concise Review
- (2015) Lavanya Joshi et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG-secreting cells
- (2015) Sayma Rahman et al. CLINICAL IMMUNOLOGY
- T-Cell Therapy: Options for Infectious Diseases: Table 1.
- (2015) Shreemanta K. Parida et al. CLINICAL INFECTIOUS DISEASES
- Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets forMycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases
- (2015) Robert N. Mahon et al. CLINICAL INFECTIOUS DISEASES
- Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
- (2015) Saїd Azoury et al. CURRENT CANCER DRUG TARGETS
- Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies
- (2015) Troels H. Borch et al. DRUG DISCOVERY TODAY
- Cellular therapy in Tuberculosis
- (2015) Shreemanta K. Parida et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment
- (2015) Rebecca Axelsson-Robertson et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis
- (2015) N. Li et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- (2015) Scott N. Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Expanded Cytotoxic T-cell Lymphocytes Target the Latent HIV Reservoir
- (2015) Julia A. Sung et al. JOURNAL OF INFECTIOUS DISEASES
- Corticosteroid therapy for pneumonia
- (2015) Alimuddin Zumla et al. LANCET
- Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
- (2015) Claudine Angela Blum et al. LANCET
- Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial
- (2015) Peter Daley et al. LANCET INFECTIOUS DISEASES
- Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
- (2015) Shruthi Ravimohan et al. LANCET INFECTIOUS DISEASES
- Phenylbutyrate induces cathelicidin expression via the vitamin D receptor: Linkage to inflammatory and growth factor cytokines pathways
- (2015) Nikhil N. Kulkarni et al. MOLECULAR IMMUNOLOGY
- Towards host-directed therapies for tuberculosis
- (2015) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
- (2015) Meenal Datta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endocannabinoid metabolism by cytochrome P450 monooxygenases
- (2015) Susan Zelasko et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome
- (2015) Rachel P. J. Lai et al. Seminars in Immunopathology
- Impact of tuberculosis treatment length and adherence under different transmission intensities
- (2015) S.T.R. Pinho et al. THEORETICAL POPULATION BIOLOGY
- Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients
- (2015) Isabel Sada-Ovalle et al. Journal of the International AIDS Society
- Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity
- (2015) Ruth J. Napier et al. PLoS Pathogens
- Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D₃
- (2015) Anna K. Coussens et al. PLoS Pathogens
- Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy
- (2015) Anna Niezgoda et al. Biomed Research International
- Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies
- (2015) Alimuddin Zumla et al. Lancet Respiratory Medicine
- PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment
- (2015) Syeda S. Hassan et al. PLoS One
- Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
- (2015) Akhirunnesa Mily et al. PLoS One
- Expression of TNF-α, IFN-γ, TGF-β, and IL-4 in the Spinal Tuberculous Focus and Its Impact on the Disease
- (2014) Hanwen Chen et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Pharmacological Inhibition of Poly(ADP-Ribose) Polymerases Improves Fitness and Mitochondrial Function in Skeletal Muscle
- (2014) Eija Pirinen et al. Cell Metabolism
- Analysis of Th1, Th17 and regulatory T cells in tuberculosis case contacts
- (2014) R.E. García Jacobo et al. CELLULAR IMMUNOLOGY
- Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion
- (2014) M. Schiebler et al. EMBO Molecular Medicine
- Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis
- (2014) Sarah Dimeloe et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Longevity loss among cured tuberculosis patients and the potential value of prevention
- (2014) S. Hoger et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- The effects of statin use on the development of tuberculosis among patients with diabetes mellitus
- (2014) Y. A. Kang et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Simvastatin increases the in vivo activity of the first-line tuberculosis regimen
- (2014) C. Skerry et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1
- (2014) Grant R. Campbell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Programmed Death (PD)-1:PD-Ligand 1/PD-Ligand 2 Pathway Inhibits T Cell Effector Functions during Human Tuberculosis
- (2014) J. O. Jurado et al. JOURNAL OF IMMUNOLOGY
- Inflammation and tuberculosis: host-directed therapies
- (2014) A. Zumla et al. JOURNAL OF INTERNAL MEDICINE
- The IL-13/IL-4Rαaxis is involved in tuberculosis-associated pathology
- (2014) Lisa Heitmann et al. JOURNAL OF PATHOLOGY
- Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines
- (2014) Alimuddin I Zumla et al. LANCET INFECTIOUS DISEASES
- Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
- (2014) Frits van Rhee et al. LANCET ONCOLOGY
- Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy
- (2014) Imran Hussain Chowdhury et al. MOLECULAR IMMUNOLOGY
- Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
- (2014) Katrin D. Mayer-Barber et al. NATURE
- Interception of host angiogenic signalling limits mycobacterial growth
- (2014) Stefan H. Oehlers et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- IL-32 is a molecular marker of a host defense network in human tuberculosis
- (2014) D. Montoya et al. Science Translational Medicine
- Metformin as adjunct antituberculosis therapy
- (2014) A. Singhal et al. Science Translational Medicine
- Immunomodulation and Immune Reconstitution in Chronic Lymphocytic Leukemia
- (2014) John C. Riches et al. SEMINARS IN HEMATOLOGY
- Programmed death-1 receptor suppresses γ-IFN producing NKT cells in human tuberculosis
- (2014) Amar Singh et al. TUBERCULOSIS
- Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial
- (2014) Aliaksandr Skrahin et al. Lancet Respiratory Medicine
- Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
- (2014) Keertan Dheda et al. Lancet Respiratory Medicine
- Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
- (2014) Stefan H E Kaufmann et al. Lancet Respiratory Medicine
- The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy
- (2014) Joanne Leung et al. Immune Network
- TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species
- (2013) Francisco J. Roca et al. CELL
- An abnormal phenotype of lung Vγ9Vδ2 T cells impairs their responsiveness in tuberculosis patients
- (2013) Sary El Daker et al. CELLULAR IMMUNOLOGY
- TB: the Yin and Yang of lipid mediators
- (2013) David M Tobin et al. CURRENT OPINION IN PHARMACOLOGY
- CD40 ligand and interferon-γ induce an antimicrobial response againstMycobacterium tuberculosisin human monocytes
- (2013) Georgiana M. Klug-Micu et al. IMMUNOLOGY
- Markers of Response for the Antiangiogenic Agent Bevacizumab
- (2013) Diether Lambrechts et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: CD1a Tetramers and Dextramers Identify Human Lipopeptide-Specific T Cells Ex Vivo
- (2013) A. G. Kasmar et al. JOURNAL OF IMMUNOLOGY
- Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
- (2013) Suraj P. Parihar et al. JOURNAL OF INFECTIOUS DISEASES
- Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
- (2013) Cristina Vilaplana et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis–Specific Interferon γ–Producing T Cells From Apoptosis in Patients With Pulmonary Tuberculosis
- (2013) Amar Singh et al. JOURNAL OF INFECTIOUS DISEASES
- Tuberculosis biomarkers discovery: developments, needs, and challenges
- (2013) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis
- (2013) BO RAM HAN et al. ONCOLOGY REPORTS
- A Broad Profile of Co-Dominant Epitopes Shapes the Peripheral Mycobacterium tuberculosis Specific CD8+ T-Cell Immune Response in South African Patients with Active Tuberculosis
- (2013) Rebecca Axelsson-Robertson et al. PLoS One
- A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
- (2013) David Gardiner et al. PLoS One
- LPS-Binding Protein and IL-6 Mark Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome in HIV Patients
- (2013) Odin Goovaerts et al. PLoS One
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Reactivation of latent HIV by histone deacetylase inhibitors
- (2013) Kotaro Shirakawa et al. TRENDS IN MICROBIOLOGY
- Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay
- (2013) Juan D Guzman et al. BMJ Open
- Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
- (2013) Thomas Rasmussen et al. Human Vaccines & Immunotherapeutics
- Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus
- (2012) Raija K Ahmed et al. BMC INFECTIOUS DISEASES
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
- (2012) David M. Tobin et al. CELL
- Dexamethasone Downregulates the Systemic Cytokine Response in Patients with Community-Acquired Pneumonia
- (2012) Hilde H. F. Remmelts et al. Clinical and Vaccine Immunology
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
- (2012) Liang Shan et al. IMMUNITY
- The Tim3-Galectin 9 Pathway Induces Antibacterial Activity in Human Macrophages Infected with Mycobacterium tuberculosis
- (2012) I. Sada-Ovalle et al. JOURNAL OF IMMUNOLOGY
- Rational Development of Adjunct Immune-Based Therapies for Drug-Resistant Tuberculosis: Hypotheses and Experimental Designs
- (2012) A. Zumla et al. JOURNAL OF INFECTIOUS DISEASES
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- Foxp3+ Regulatory T Cells among Tuberculosis Patients: Impact on Prognosis and Restoration of Antigen Specific IFN-γ Producing T Cells
- (2012) Amar Singh et al. PLoS One
- Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa
- (2012) Kathryn Schnippel et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Prospects for TIM3-Targeted Antitumor Immunotherapy
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
- (2011) Ruth J. Napier et al. Cell Host & Microbe
- Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis
- (2011) Finlay W. McNab et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development
- (2011) Gerritje J.W. van der Windt et al. IMMUNITY
- Valproic Acid Increases Formation of Reactive Oxygen Species and Induces Apoptosis in Postimplantation Embryos: A Role for Oxidative Stress in Valproic Acid-Induced Neural Tube Defects
- (2011) E. W. Y. Tung et al. MOLECULAR PHARMACOLOGY
- Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
- (2011) Noah S Butler et al. NATURE IMMUNOLOGY
- Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines
- (2011) J. Fu et al. NEURO-ONCOLOGY
- Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells
- (2011) Luca A. Petruccelli et al. PLoS One
- A Novel in vitro Human Macrophage Model to Study the Persistence of Mycobacterium tuberculosis Using Vitamin D3 and Retinoic Acid Activated THP-1 Macrophages
- (2011) Jaymie L. Estrella et al. Frontiers in Microbiology
- A high-throughput respirometric assay for mitochondrial biogenesis and toxicity
- (2010) Craig C. Beeson et al. ANALYTICAL BIOCHEMISTRY
- Pulmonary impairment after tuberculosis and its contribution to TB burden
- (2010) Jotam G Pasipanodya et al. BMC PUBLIC HEALTH
- Selective Depletion of CD4+CD25+Foxp3+Regulatory T Cells by Low-Dose Cyclophosphamide Is Explained by Reduced Intracellular ATP Levels
- (2010) Jie Zhao et al. CANCER RESEARCH
- The Role of Histone Deacetylase Inhibitors in the Treatment of Patients With Cutaneous T-Cell Lymphoma
- (2010) Kenneth B. Hymes Clinical Lymphoma Myeloma & Leukemia
- The CD4-like molecule LAG-3, biology and therapeutic applications
- (2010) Sophie Sierro et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Cytotoxic therapy for severe swine flu A/H1N1
- (2010) Jan-Inge Henter et al. LANCET
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
- (2010) Matthew P. R. Berry et al. NATURE
- Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors
- (2009) Nancie M Archin et al. AIDS
- Adalimumab Treatment of Life‐Threatening Tuberculosis
- (2009) Robert S. Wallis et al. CLINICAL INFECTIOUS DISEASES
- Novel Relationship between Tuberculosis Immune Reconstitution Inflammatory Syndrome and Antitubercular Drug Resistance
- (2009) Graeme Meintjes et al. CLINICAL INFECTIOUS DISEASES
- Eicosanoids in inflammation and cancer: the role of COX-2
- (2009) Smita Agarwal et al. Expert Review of Clinical Immunology
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
- (2009) Shundong Cang et al. Journal of Hematology & Oncology
- Enhancing CD8 T-cell memory by modulating fatty acid metabolism
- (2009) Erika L. Pearce et al. NATURE
- Prior Statin Use Is Associated with Improved Outcomes in Community-acquired Pneumonia
- (2008) James D. Chalmers et al. AMERICAN JOURNAL OF MEDICINE
- Preadmission Use of Statins and Outcomes After Hospitalization With Pneumonia
- (2008) Reimar W. Thomsen et al. ARCHIVES OF INTERNAL MEDICINE
- Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors
- (2008) Alfonso Duenas-Gonzalez et al. CANCER TREATMENT REVIEWS
- IL-15 as a mediator of CD4+help for CD8+T cell longevity and avoidance of TRAIL-mediated apoptosis
- (2008) SangKon Oh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High levels of intracellular IL-4 are expressed in circulating apoptotic T cells in patients with tuberculosis and in community controls
- (2007) Hanne Veenstra et al. TUBERCULOSIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started